Burnett Patrick bought ARQT
December 15, 2025 · Form 4 insider transaction
Burnett Patrick bought 11,500 shares of Arcutis Biotherapeutics, Inc. at $3.64 per share, a transaction worth $41.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,500
Price
$3.64
Total value
$41.9K
InsiderBurnett Patrick
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after109,807
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.; Due to a scrivener's error on the Reporting Person's Form 4 filed on November 5, 2025, the number of shares of common stock beneficially owned by the Reporting Person was inadvertently overstated by 18 shares. The corrected number of shares beneficially owned is reflected in this Form 4.